What Is Gene Therapy?

Many diseases are caused or influenced by changes in:

DNA.

A change in DNA is called a:

mutation.

If a mutation affects an important gene, the cell may produce an abnormal protein, produce too little of a protein, or fail to produce the protein at all.

Gene therapy is an approach that treats or prevents disease by changing genetic material or how genes function in a patient's cells.

The basic idea is:

Genetic problem → change gene function → improve cell function → treat disease

Gene therapy attempts to address a biological cause of disease rather than only treating its:

symptoms.

---

Why Can Genes Cause Disease?

Genes contain instructions used by cells to make functional products, often:

proteins.

A simplified relationship is:

DNA → RNA → protein → cell function

If a mutation changes an important gene:

Mutation → altered gene function → altered protein → altered cell function → possible disease

Gene therapy attempts to intervene somewhere in this process.

---

The Purpose of Gene Therapy

The main purpose of gene therapy is to modify genetic function in cells to:

treat or prevent disease.

Depending on the condition, scientists may try to:

• provide a working copy of a gene
• replace missing gene function
• disable a harmful gene
• change how strongly a gene is expressed
• edit a mutation
• genetically modify cells so they can perform a useful function

Different diseases require different:

strategies.

---

Gene Addition

One approach is to provide cells with a functioning copy of a:

gene.

Imagine a person has two non-functioning copies of a gene needed to produce Protein X.

Their cells cannot make enough functional:

Protein X.

Gene therapy may introduce a working version of the gene.

The cell can then potentially produce functional Protein X.

This is sometimes called:

gene addition or gene augmentation.

---

Gene Editing

Another approach is to change the DNA sequence itself.

This is called:

gene editing.

Gene editing may allow scientists to:

• correct a mutation
• remove part of a gene
• disable a harmful gene
• insert genetic material
• alter gene regulation

One important gene-editing technology is:

CRISPR-Cas.

---

CRISPR-Cas9

CRISPR-Cas9 can be designed to target particular regions of:

DNA.

A simplified model involves:

guide RNA → identifies target DNA

and:

Cas9 → cuts the DNA

The cell then repairs the DNA.

Scientists can sometimes use this repair process to create a desired genetic:

change.

---

Gene Silencing

Sometimes disease results from a gene producing a harmful product.

In this situation, scientists may want to reduce the activity of that:

gene.

This is sometimes described as:

gene silencing.

Instead of adding a missing function, the goal is to:

reduce harmful gene activity.

---

Gene Therapy and Genetic Disorders

A genetic disorder results from changes in genes or chromosomes that interfere with normal biological:

function.

Examples include:

• sickle cell disease
• cystic fibrosis
• hemophilia
• some inherited immune disorders
• some inherited forms of blindness
• some muscular disorders

Gene therapy may be particularly useful when scientists understand which gene contributes to the disorder.

---

A Simplified Example

Imagine a disorder caused by a defective gene.

Normal situation:

Working gene → functional protein → normal cell function

Genetic disorder:

Mutated gene → abnormal or missing protein → impaired cell function

Gene therapy:

Therapeutic genetic change → restored or improved protein function → improved cell function

The exact process depends on the particular:

disease.

---

Getting the Therapy Into Cells

One of the biggest challenges is delivering genetic material to the correct:

cells.

DNA and other therapeutic molecules cannot simply be placed anywhere in the body and expected to reach the correct cells.

Scientists often need a:

delivery system.

A delivery system used to carry genetic material into cells is called a:

vector.

---

Viral Vectors

Viruses naturally have the ability to enter cells and deliver genetic:

material.

Scientists can modify some viruses so they can act as:

vectors.

Genes involved in causing disease are removed or disabled, and therapeutic genetic material can be placed into the vector.

The modified vector is then used to deliver the therapy into target:

cells.

---

Viruses as Delivery Vehicles

A useful analogy is a:

delivery vehicle.

The therapeutic genetic material is the:

package.

The viral vector is the:

vehicle.

The target cell is the:

destination.

Scientists modify the vehicle so that it delivers the therapeutic material without producing the original viral disease.

---

Common Viral Vectors

Different viruses have different biological properties.

Vectors used in gene therapy can include modified forms of:

• adeno-associated viruses
• adenoviruses
• lentiviruses
• retroviruses

Different vectors are suited to different cells and therapeutic:

purposes.

Choosing the correct vector is an important part of designing a gene therapy.

---

Non-Viral Delivery

Gene therapy does not always require:

viruses.

Scientists are also developing non-viral delivery systems.

These can include:

• lipid nanoparticles
• engineered particles
• direct delivery of nucleic acids
• physical methods of introducing genetic material

Each method has advantages and:

limitations.

---

Two Major Approaches

Gene therapy can be performed using two broad strategies:

in vivo

and:

ex vivo.

Understanding the difference is important.

---

In Vivo Gene Therapy

In vivo means:

inside the living organism.

In in vivo gene therapy, the treatment is delivered directly into the patient's:

body.

The vector or genetic material must then reach the target cells.

A simplified sequence is:

Therapy administered → vector reaches target tissue → genetic material enters cells → gene function changes

---

Ex Vivo Gene Therapy

Ex vivo means:

outside the living organism.

Cells are removed from the patient and modified in a:

laboratory.

The modified cells are then returned to the patient.

The process can be summarized as:

Remove cells → modify cells → test/select cells → return cells to patient

This gives scientists more control over which cells are genetically modified.

---

In Vivo vs Ex Vivo

In Vivo

Genetic material is delivered directly into the:

patient.

Useful when target cells cannot easily be removed and returned.

Ex Vivo

Cells are removed and genetically modified outside the:

body.

Useful when cells such as blood-forming stem cells can be collected, modified, and returned.

---

Somatic Gene Therapy

Most current gene therapies target:

somatic cells.

Somatic cells are the body's non-reproductive:

cells.

Examples include:

• blood cells
• liver cells
• muscle cells
• retinal cells

Changes made to somatic cells are generally not inherited by the patient's:

children.

---

Germline Gene Therapy

Germline modification would involve genetic changes that could be passed to future:

generations.

This could involve:

• egg cells
• sperm cells
• cells that produce gametes
• very early embryos in ways that make changes heritable

Heritable genome editing raises major scientific, safety, ethical, and social:

questions.

It is fundamentally different from treating somatic cells in an individual patient.

---

Example: Sickle Cell Disease

Sickle cell disease is caused by variants affecting:

hemoglobin.

Hemoglobin is the protein in red blood cells that carries:

oxygen.

The condition affects the shape and behaviour of red blood cells and can cause serious health problems.

Gene-based therapies can modify a patient's blood-forming:

stem cells.

---

Simplified Sickle Cell Gene Therapy

A simplified ex vivo approach might involve:

1. Collect blood-forming stem cells from the patient.

2. Genetically modify those cells.

3. Prepare the patient to receive the modified cells.

4. Return the modified stem cells.

5. Allow the cells to produce new blood cells.

The goal is to produce red blood cells with improved hemoglobin:

function.

---

Why Stem Cells Are Useful

Stem cells can:

self-renew

and can produce specialized cell types.

Blood-forming stem cells can produce:

• red blood cells
• several types of white blood cells
• platelets

If blood-forming stem cells are successfully modified, they can potentially produce large numbers of genetically altered descendant:

cells.

---

Gene Therapy and Immune Disorders

Some inherited disorders prevent parts of the immune system from functioning:

properly.

If the problem is caused by a particular defective gene, scientists may modify blood-forming stem cells to provide or restore the missing genetic:

function.

The modified cells can then produce immune cells with improved function.

---

Gene Therapy and Inherited Blindness

Some forms of inherited vision loss are caused by mutations affecting cells in the:

retina.

The retina is the light-sensitive tissue at the back of the:

eye.

Gene therapy can sometimes deliver therapeutic genetic material to retinal cells.

The aim is to improve or preserve:

visual function.

---

Gene Therapy and Cancer

Gene therapy can also be used in ways that help the immune system attack:

cancer.

One important example involves genetically modifying a patient's immune:

cells.

The cells can be engineered to recognize particular molecules on cancer cells.

They are then returned to the patient.

This approach demonstrates that gene therapy is not limited to inherited genetic disorders.

---

CAR-T Cell Therapy

In CAR-T cell therapy, T cells are collected from a patient.

The cells are genetically modified so that they produce a:

chimeric antigen receptor (CAR).

This receptor helps the T cells recognize particular cancer:

cells.

The modified cells are multiplied and returned to the patient.

---

Potential Benefit: Treating the Cause

Many traditional treatments manage:

symptoms.

Gene therapy may sometimes target an underlying molecular cause of a:

disease.

For a disorder caused by loss of gene function, restoring that function may improve the biological process responsible for the condition.

This makes gene therapy fundamentally different from many conventional treatments.

---

Potential Benefit: Long-Lasting Effects

Some gene therapies may produce effects lasting for:

years.

If long-lived cells or stem cells are successfully modified, the therapeutic effect may continue as those cells survive or produce:

descendants.

This creates the possibility that some conditions could be treated with relatively few treatment procedures.

However, duration varies considerably between therapies.

---

Potential Benefit: Treating Previously Difficult Diseases

Some genetic disorders have historically had few effective:

treatments.

Gene therapy may provide new possibilities when conventional medicines cannot replace a missing genetic function.

This is particularly important for some rare inherited:

diseases.

---

Potential Benefit: Precision

Gene therapy can sometimes be designed around a particular:

molecular problem.

Instead of affecting the entire body in the same way, the treatment may target:

• particular cells
• particular tissues
• particular genes
• particular mutations

This creates opportunities for increasingly:

precise medicine.

---

Challenge: Delivering the Therapy

One of the greatest challenges is getting the treatment to the correct:

cells.

A therapy must often:

reach the correct tissue → enter the correct cells → deliver its genetic material → produce the desired effect

Some tissues are much easier to target than others.

---

Challenge: Immune Responses

The immune system protects the body against foreign:

materials.

It may recognize a viral vector or newly produced protein as foreign.

This can cause an:

immune response.

An immune response may reduce the effectiveness of treatment or create safety concerns.

---

Challenge: Off-Target Effects

Gene editing aims to modify a particular DNA:

sequence.

However, an editing system may sometimes alter unintended locations.

These are called:

off-target effects.

Researchers work to make gene-editing systems increasingly precise.

---

Challenge: Insertional Effects

Some vectors insert genetic material into the cell's:

chromosomes.

If insertion occurs in an unfortunate location, it could disrupt important genes or alter gene:

regulation.

This is one reason long-term safety monitoring can be important for some gene therapies.

---

Challenge: Not Every Cell Is Corrected

Imagine a tissue containing:

one million cells.

If only a small fraction receives the therapeutic genetic material, the treatment might not provide enough:

benefit.

Scientists therefore need to consider:

delivery efficiency.

The required percentage of modified cells depends on the disease.

---

Challenge: Temporary Effects

Some cells are replaced frequently.

Other treatments may not permanently alter the relevant:

cells.

As a result, the therapeutic effect might decrease over:

time.

Some gene therapies may therefore require additional treatment or alternative strategies.

---

Challenge: Complex Diseases

Gene therapy is conceptually simpler when a disorder is mainly caused by a mutation in a:

single gene.

Many common diseases are influenced by:

• many genes
• environment
• lifestyle
• development
• interactions between biological systems

These are called:

complex or multifactorial diseases.

They are much more difficult to address through a single genetic change.

---

Challenge: Cost

Developing gene therapies can be extremely:

expensive.

Costs arise from:

• research
• clinical trials
• specialized manufacturing
• genetic testing
• individualized treatment procedures
• hospital care
• long-term monitoring

This raises questions about who can:

access treatment.

---

Access and Equity

If a therapy exists but very few people can access it, an important social problem remains.

Questions include:

• Who should pay for treatment?
• Should rare-disease therapies receive special funding?
• How can treatments reach lower-income countries?
• How should healthcare systems determine access?
• How can manufacturing costs be reduced?

Gene therapy therefore involves both biological and:

social challenges.

---

Ethical Questions

Gene therapy can raise important ethical questions.

For example:

• Which conditions should be treated genetically?
• Who decides whether a genetic change is appropriate?
• How should patients give informed consent?
• Should embryos ever be genetically modified?
• Should genetic changes be inherited?
• How should genetic information be protected?
• How can equal access be encouraged?

These questions do not have purely scientific answers.

---

Treatment vs Enhancement

An important ethical distinction is between:

treatment

and:

enhancement.

Treatment attempts to prevent or treat disease.

Enhancement would attempt to change characteristics in healthy individuals beyond treating disease.

Possible hypothetical examples might involve attempts to influence:

• physical characteristics
• athletic performance
• appearance

This raises different scientific and ethical issues.

---

Gene Therapy vs Genetic Engineering

Genetic engineering is the broad process of deliberately changing genetic material.

Gene therapy uses genetic modification specifically for:

medical purposes.

Therefore:

Gene therapy is an application of genetic engineering.

---

Gene Therapy vs Cloning

These concepts are also different.

Cloning

produces genetically identical or nearly identical copies.

Gene therapy

changes genetic function to treat or prevent disease.

Gene therapy does not normally aim to produce a copy of an:

organism.

---

Gene Therapy vs Traditional Medicine

Traditional medicines may:

• block receptors
• replace chemicals
• kill microorganisms
• reduce inflammation
• change enzyme activity

Gene therapy attempts to alter genetic function within:

cells.

Both approaches can be useful, and gene therapy does not replace all conventional medicine.

---

Evaluating a Gene Therapy

When evaluating a proposed gene therapy, scientists should ask:

What disease is being treated?

Which gene or cellular pathway is involved?

Which cells must be targeted?

How will the therapy reach those cells?

How effective is the treatment?

How long does the effect last?

What are the risks?

What alternatives are available?

Can patients realistically access the treatment?

---

Future Possibility: More Precise Gene Editing

Gene-editing technologies continue to become more:

precise.

Future developments may allow scientists to correct genetic changes while reducing unintended:

effects.

Researchers are developing approaches that can make smaller, more targeted DNA changes.

---

Base Editing

Traditional CRISPR-Cas9 often involves cutting both strands of:

DNA.

Another approach called:

base editing

can change certain individual DNA bases without necessarily creating a double-strand DNA break.

This may provide useful approaches for mutations involving single:

nucleotides.

---

Prime Editing

Another developing technology is:

prime editing.

Prime editing is designed to make particular DNA changes with considerable precision.

Potential changes include some:

• substitutions
• insertions
• deletions

Research continues into its effectiveness, delivery, and safety.

---

Future Possibility: Personalized Gene Therapy

People with the same general disorder can sometimes carry different:

mutations.

Future therapies may increasingly be designed around an individual's specific:

genetic change.

This is part of the broader development of:

personalized medicine.

---

Future Possibility: More Treatable Diseases

As scientists learn more about:

• genes
• proteins
• disease pathways
• delivery systems
• gene regulation
• genome editing

the number of conditions that might be approached using gene therapy could:

increase.

However, every new therapy requires careful testing for safety and effectiveness.

---

Future Possibility: Better Delivery Systems

A powerful gene-editing tool is useful only if it can reach the correct:

cells.

Future progress may therefore depend heavily on improved:

delivery technologies.

Researchers are developing vectors and nanoparticles that may target particular tissues more effectively.

---

Future Possibility: Regenerative Medicine

Gene therapy may increasingly combine with:

stem-cell technology.

Scientists may eventually become better able to:

collect cells → repair genetic defects → grow healthy cells → return them to the patient

This could expand possibilities in:

regenerative medicine.

---

Future Possibility: One-Time Treatments

One major goal is to create treatments that provide long-lasting benefits after:

a single intervention.

For some conditions, this is already becoming possible.

For others, maintaining a safe and lasting effect remains a major scientific challenge.

---

Worked Example 1

A person has a disorder because their cells cannot produce a functional version of Protein A.

Scientists introduce a functioning copy of the gene.

What is the purpose?

To allow cells to produce:

functional Protein A.

This is an example of:

gene addition therapy.

---

Worked Example 2

Scientists remove blood-forming stem cells from a patient, modify them in a laboratory, and return them.

Is this in vivo or ex vivo therapy?

Ex vivo gene therapy.

The cells are modified:

outside the patient's body.

---

Worked Example 3

A therapeutic vector is injected directly into the eye to target retinal cells.

What type of approach is this?

In vivo gene therapy.

The therapy is delivered directly into the:

patient.

---

Worked Example 4

A gene-editing system changes DNA at an unintended location.

What is this called?

An:

off-target effect.

This represents a potential safety concern.

---

Worked Example 5

A therapy changes genes in a person's liver cells.

Will the change normally be inherited by their children?

No.

Liver cells are:

somatic cells.

Changes to somatic cells are generally not passed through reproduction.

---

Worked Example 6

A treatment successfully corrects a mutation but costs so much that very few patients can receive it.

What challenge does this illustrate?

Access and affordability.

A therapy's usefulness depends not only on whether it works biologically but also on whether patients can realistically receive it.

---

Common Mistake: Gene Therapy Replaces All of a Person's DNA

Gene therapy generally targets particular genes or genetic:

functions.

It does not replace the patient's entire:

genome.

---

Common Mistake: Gene Therapy Changes Every Cell

Most gene therapies target specific:

cells or tissues.

Other cells in the body may remain genetically unchanged.

---

Common Mistake: All Gene Therapy Changes Are Inherited

Most gene therapies involve:

somatic cells.

These changes generally affect the treated person but are not inherited by their children.

---

Common Mistake: Gene Therapy Always Uses Viruses

Modified viruses are important vectors, but non-viral delivery methods also:

exist.

Gene therapy is therefore not limited to viral vectors.

---

Common Mistake: Gene Therapy and Cloning Are the Same

Cloning produces genetic copies.

Gene therapy attempts to:

change genetic function for medical benefit.

They have very different purposes.

---

Common Mistake: Gene Therapy Can Easily Treat Any Genetic Disease

Different diseases present very different:

challenges.

A successful treatment depends on:

• understanding the disease
• identifying appropriate genetic targets
• reaching the correct cells
• producing enough therapeutic effect
• avoiding serious side effects

Complex diseases involving many genes can be especially difficult.

---

Common Mistake: Editing DNA Is Automatically Permanent

Some genetic changes can be long-lasting, but the overall therapeutic effect depends on:

• which cells were modified
• how long those cells survive
• whether they divide
• whether enough cells were successfully treated

Therefore, gene therapy is not automatically a permanent cure.

---

Check Your Understanding

1. Define gene therapy.

2. What is the main purpose of gene therapy?

3. Explain how a mutation can cause disease.

4. How can adding a functional gene help treat a genetic disorder?

5. What is gene editing?

6. What is gene silencing?

7. What is CRISPR-Cas9?

8. What is a vector?

9. Why can viruses be useful as gene-therapy vectors?

10. Why must viral vectors be modified before they are used therapeutically?

11. Give one example of a non-viral delivery system.

12. What is in vivo gene therapy?

13. What is ex vivo gene therapy?

14. Explain the difference between in vivo and ex vivo treatment.

15. What is a somatic cell?

16. Why are most gene-therapy changes not inherited?

17. What is germline modification?

18. Why does germline modification raise additional ethical concerns?

19. Explain how blood-forming stem cells can be used in gene therapy.

20. Describe how gene-based therapy can help treat sickle cell disease.

21. Explain one way gene therapy can be used to treat inherited blindness.

22. How can genetically modified immune cells help treat cancer?

23. What is CAR-T cell therapy?

24. Give three potential benefits of gene therapy.

25. Why might gene therapy provide long-lasting effects?

26. Why is delivery one of the major challenges of gene therapy?

27. What is an immune response to a vector?

28. What is an off-target effect?

29. Why can inserting DNA into chromosomes sometimes create risks?

30. Why might modifying only a small number of cells be insufficient?

31. Why are complex diseases difficult to treat with gene therapy?

32. Explain why gene therapy can be expensive.

33. Why is access to gene therapy an ethical and social issue?

34. Explain the difference between treatment and enhancement.

35. Explain the difference between gene therapy and cloning.

36. Explain the relationship between genetic engineering and gene therapy.

37. What is base editing?

38. What is personalized gene therapy?

39. Describe two possible future developments in gene therapy.

40. A new gene therapy successfully treats a disorder but has a small risk of serious side effects and is extremely expensive. What information would you consider when evaluating the treatment?

---

Key Terms

• Gene therapy: Treatment or prevention of disease by changing genetic material or gene function in a patient's cells.
• Mutation: Change in a DNA sequence.
• Genetic disorder: Disease caused or influenced by changes in genetic material.
• Gene addition: Introduction of functional genetic material to restore or improve gene function.
• Gene editing: Targeted alteration of DNA.
• Gene silencing: Reduction of the activity or expression of a gene.
• CRISPR-Cas: Gene-editing system capable of targeting specific DNA sequences.
• Vector: Delivery system used to transport therapeutic genetic material into cells.
• Viral vector: Modified virus used to deliver genetic material.
• In vivo: Treatment performed directly inside the patient's body.
• Ex vivo: Treatment in which cells are removed, modified outside the body, and returned.
• Somatic cell: Non-reproductive body cell.
• Germline: Cells or genetic material capable of contributing to future generations.
• Stem cell: Cell capable of self-renewal and producing other cell types.
• CAR-T cell: Genetically modified T cell designed to recognize particular cancer cells.
• Off-target effect: Unintended genetic modification at a location other than the intended target.
• Base editing: Gene-editing approach capable of changing certain individual DNA bases.
• Prime editing: Gene-editing approach designed to make targeted DNA substitutions, insertions, or deletions.
• Personalized medicine: Medical treatment adapted to characteristics of an individual patient.
• Regenerative medicine: Field concerned with repairing or replacing damaged cells, tissues, or organs.

---

Key Takeaways

• Gene therapy aims to treat or prevent disease by changing genetic function.
• Genetic disorders can occur when mutations interfere with the production or function of important proteins.
• Gene therapy may add a functioning gene, edit DNA, or reduce harmful gene activity.
• Gene therapy attempts to address an underlying biological cause of some diseases.
• CRISPR-Cas is one important gene-editing technology.
• Genetic material must reach the correct cells for treatment to work.
• A vector carries therapeutic genetic material into cells.
• Modified viruses can be used as gene-therapy vectors.
• Non-viral delivery systems are also being developed.
• In vivo therapy delivers treatment directly into the patient's body.
• Ex vivo therapy modifies cells outside the body before returning them to the patient.
• Most current gene therapies modify somatic cells.
• Somatic genetic changes are generally not inherited by future generations.
• Heritable germline modification raises additional safety and ethical concerns.
• Gene-based therapies can be used for some inherited disorders.
• Blood-forming stem cells are important targets for some ex vivo therapies.
• Gene therapy approaches are used for conditions including sickle cell disease and some inherited forms of blindness.
• Genetically modified immune cells can also be used to treat some cancers.
• CAR-T therapy genetically modifies T cells to recognize particular cancer cells.
• Potential benefits include targeting underlying disease mechanisms and producing long-lasting effects.
• Gene therapy may provide options for diseases that previously had few effective treatments.
• Important challenges include delivery, immune responses, off-target effects, effectiveness, durability, and safety.
• Complex diseases involving many genes and environmental factors are especially challenging.
• Gene therapies can be expensive to develop and manufacture.
• Cost and access raise important questions about healthcare equity.
• Gene therapy raises ethical questions involving consent, privacy, treatment, enhancement, and heritable genetic changes.
• Gene therapy is an application of genetic engineering, but it is not the same as cloning.
• New technologies such as base editing and prime editing may allow increasingly precise genetic changes.
• Improved delivery systems may expand the range of tissues that can be treated.
• Gene therapy may increasingly combine with stem-cell and regenerative medicine.
• Future therapies may become more personalized to individual mutations.
• A new gene therapy should be evaluated using evidence about its effectiveness, safety, durability, accessibility, alternatives, and ethical implications.